Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.700
-0.040 (-1.46%)
At close: Aug 17, 2026, 4:00 PM EDT
2.790
+0.090 (3.33%)
After-hours: Aug 17, 2026, 7:34 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $119.9 million as of August 17, 2026. Its market cap has decreased by -9.80% in one year.
Market Cap
119.90M
Enterprise Value
103.65M
1-Year Change
-9.80%
Ranking
Category
Stock Price
$2.70
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $119.90M, a decrease of -15.38%. That is a compound annual growth rate of -4.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 119.90M | -26.90% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 133.26M |
| Polaryx Therapeutics | 129.60M |
| Indaptus Therapeutics | 121.17M |
| Vivani Medical | 120.73M |
| Inovio Pharmaceuticals | 119.51M |
| Yarrow Bioscience | 118.97M |
| Black Diamond Therapeutics | 116.06M |
| Seer, Inc. | 115.17M |